Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study

Affiliations

Sandra P. Smieszek: Vanda Pharmaceuticals Inc., Washington, DC, United States
Alyssa R. Kaden: Vanda Pharmaceuticals Inc., Washington, DC, United States
Caroline E. Johnson: Vanda Pharmaceuticals Inc., Washington, DC, United States
Jennifer L. Brzezynski: Vanda Pharmaceuticals Inc., Washington, DC, United States
Changfu Xiao: Vanda Pharmaceuticals Inc., Washington, DC, United States
Christos M. Polymeropoulos: Vanda Pharmaceuticals Inc., Washington, DC, United States
Gunther Birznieks: Vanda Pharmaceuticals Inc., Washington, DC, United States
Helene A. Emsellem: The Center for Sleep & Wake Disorders, Chevy Chase, MD, United States
Helene A. Emsellem: Department of Neurology, George Washington University, Washington, DC, United States
Mihael H. Polymeropoulos: Vanda Pharmaceuticals Inc., Washington, DC, United States

Abstract

No abstracts available.

ISSN: 1662-4548 (Print); 1662-453X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: http://www.frontiersin.org/neuroscience